name
given
world
health
organ
recent
coronaviru
associ
diseas
becom
wellknown
term
around
world
recent
first
report
infect
made
decemb
wuhan
china
seri
pneumonia
unknown
caus
link
novel
kind
coronaviru
decemb
caus
agent
diseas
envelop
posit
sens
rna
viru
belong
betacoronaviru
genera
coronavirida
famili
although
group
virus
usual
induc
mild
cold
condit
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
identifi
famili
sever
year
ago
caus
deadli
seriou
respiratori
diseas
spite
lower
fatal
rate
merscov
sarscov
risk
regard
seriou
mainli
high
transmiss
viru
abil
surviv
long
hour
differ
surfac
moreov
report
show
may
caus
insignific
flulik
symptom
mani
contamin
peopl
easili
infect
other
societi
basi
declar
public
health
emerg
intern
concern
outbreak
prompt
major
global
nation
health
organ
announc
research
prioriti
dedic
huge
fund
relat
investig
meet
assess
current
knowledg
viral
diseas
determin
research
direct
held
collabor
glopidr
global
research
collabor
infecti
diseas
prepared
particip
scientist
variou
disciplin
funder
differ
part
world
still
mani
unknown
viru
great
effort
taken
find
answer
question
viru
behavior
transmiss
aspect
genom
sequenc
chines
research
midjanuari
atom
structur
viru
spike
protein
also
reveal
cryoem
techniqu
one
month
later
special
help
vaccin
design
differ
approach
adopt
variou
research
team
compani
fight
vaccin
tremend
success
strategi
medic
histori
certainli
among
field
research
first
batch
mrna
messeng
rna
vaccin
develop
moderna
therapeut
fund
coalit
epidem
prepared
innov
cepi
produc
recent
sent
nation
institut
allergi
infecti
diseas
niaid
part
nation
institut
health
nih
human
test
plan
start
april
novavax
compani
start
preclin
studi
anim
model
test
sever
vaccin
candid
vaccin
contain
antigen
coronaviru
spike
protein
base
compani
recombin
protein
nanoparticl
technolog
platform
compani
curevac
tonix
pharmaceut
also
begun
research
vaccin
develop
sever
compani
announc
partnership
project
includ
geovax
bravovax
taki
evvivax
ibio
ccpharm
univers
queensland
also
announc
team
progress
creat
vaccin
regeneron
pharmaceut
also
collabor
use
platform
geneticallyengin
mous
human
immun
system
gsk
also
take
share
develop
vaccin
use
pandem
vaccin
adjuv
platform
technolog
support
immun
system
induct
antivir
drug
also
wide
investig
find
effect
agent
favilavir
first
drug
approv
nation
medic
product
administr
china
treatment
follow
clinic
trial
conduct
patient
china
earli
result
clinic
trial
use
chloroquin
phosphat
old
antimalaria
drug
patient
promis
therefor
cocktail
protocol
present
use
treat
patient
usag
chloroquin
phosphat
avail
drug
recommend
gilead
start
two
larg
phase
studi
evalu
safeti
efficaci
remdesivir
rna
polymeras
inhibitor
first
develop
ebola
adult
patient
diagnos
base
posit
preliminari
investig
previou
result
shown
merscov
drug
lopinavirritonavir
interferon
beta
indic
efficaci
anim
model
merscov
also
test
battl
know
enemi
major
step
defeat
despit
sorrow
news
announc
everi
day
regard
wider
spread
differ
countri
higher
number
death
knowledg
tini
viru
increas
day
day
take
advantag
gather
data
previou
experi
sar
mer
get
closer
find
way
conquer
diseas
hope
near
futur
meanwhil
implement
prevent
strategi
collabor
countri
around
globe
utmost
import
lower
threat
